Glenn Petrie, Ph.D, is a Senior Scientific Advisor at EAG Laboratories. He has over 20 years of experience in the drug development arena with a focus on biopharmaceuticals. As a director at a major CRO he has served as team leader in the development, Chemistry Manufacture and Control (CMC) design and IND submissions for a wide variety of biopharmaceuticals (monoclonal antibodies, drug conjugates, peptides, etc.). Petrie is a subject matter expert in the analysis of proteins including HPLC, mass spectroscopy, ELISAs and electrophoresis. He received his B.A. in Biochemistry at Rice University and his doctorate in Biochemistry at the University of Illinois Urbana-Champaign.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.